Tolazamide |
Tolinase |
Article: Tolazamide
![]() | |
| Tolazamide | |
| Systematic (IUPAC) name | |
| 3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea | |
| Identifiers | |
| CAS number | 1156-19-0 |
| ATC code | A10BB05 |
| PubChem | 5503 |
| DrugBank | APRD01267 |
| Chemical data | |
| Formula | C14H21N3O3S |
| Mol. weight | 311.401 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | ? |
Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes. It is part of the sulfonamide family (ATC A10BB).

Not Signed In - 


